Tenet Healthcare Corporation (NYSE: THC), a prominent player in the healthcare sector, is capturing investor attention with its robust buy ratings and promising upside potential. As a diversified healthcare services..
Royalty Pharma plc (NASDAQ: RPRX), a notable player in the biotechnology sector, stands out with its unique business model as a buyer of biopharmaceutical royalties and a funder of innovation...
Baxter International Inc. (BAX), a stalwart in the healthcare sector, is known for its wide-ranging portfolio of medical products and therapies. Headquartered in Deerfield, Illinois, Baxter operates globally, catering to..
Atrium Therapeutics, Inc. (NASDAQ: RNA), a promising player in the biotechnology sector, is capturing investor attention with its potential to revolutionize RNA therapeutics for cardiomyopathies. With a market capitalization of..
Medpace Holdings, Inc. (NASDAQ: MEDP) is a standout player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $15.36 billion, Medpace is a..
Teva Pharmaceutical Industries (NYSE: TEVA), a prominent player in the healthcare sector, is capturing investor attention with its significant potential upside of 27.69%, as indicated by current analyst ratings. With..
Investors seeking opportunities in the healthcare sector might find Encompass Health Corporation (NYSE: EHC) to be a compelling option. As a leading provider in the medical care facilities industry, Encompass..
Charles River Laboratories International, Inc. (NYSE: CRL), a stalwart in the healthcare sector, particularly in diagnostics and research, commands a notable presence with its $10.81 billion market cap. Headquartered in..
IQVIA Holdings, Inc. (NYSE: IQV) stands as a formidable player in the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $34.42 billion, IQVIA offers..
Legend Biotech Corporation (NASDAQ: LEGN) has carved a niche in the biotechnology sector with its focus on pioneering cell therapies for oncology. With a market capitalization of $4.31 billion, this..
Revvity, Inc. (NYSE: RVTY), a significant player in the healthcare sector, is capturing investor attention with its robust presence in the diagnostics and research industry. With a market cap of..
McKesson Corporation (NYSE: MCK) stands at the forefront of the healthcare distribution industry, with an impressive market capitalization of $98.51 billion. As a key player in the medical distribution sector,..
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a notable player in the biotechnology sector, is capturing attention with its robust portfolio of therapies aimed at central nervous system (CNS) disorders. Based in..
Regencell Bioscience Holdings Limited (NASDAQ: RGC) presents an intriguing opportunity for investors interested in the burgeoning field of Traditional Chinese Medicine (TCM). With a market capitalization of $2.48 billion, this..
Oscar Health, Inc. (NYSE: OSCR) is emerging as a noteworthy player in the healthcare sector, particularly within the healthcare plans industry. With its market capitalization standing at $8.77 billion, the..
IDEXX Laboratories, Inc. (NASDAQ: IDXX) is making waves in the healthcare sector, particularly within the diagnostics and research industry, with a market capitalization of $44.76 billion. Based in the United..
Danaher Corporation (NYSE: DHR), a stalwart in the healthcare sector, particularly in the diagnostics and research industry, continues to capture investor attention with its robust market presence and promising growth..
Cardinal Health, Inc. (NYSE: CAH) stands as a pivotal player in the healthcare sector, particularly in the medical distribution industry. With a market capitalization of $53.52 billion, Cardinal Health serves..
Smith & Nephew SNATS, Inc. (NYSE: SNN), a venerable name in the medical devices industry, is making waves with intriguing potential for investors. Headquartered in Watford, United Kingdom, this healthcare..
For investors with an eye on the healthcare sector, Globus Medical, Inc. (NYSE: GMED) presents a compelling opportunity, particularly given the company’s potential upside of 37.34%. As a leader in..
